DOI: 10.3390/vaccines14100866 ISSN: 2076-393X

Epitope Mapping and MHC Restriction of Next-Generation Tuberculosis Vaccine Antigens in Mice

Samuel J. Vidal, Alejandro A. Espinosa Perez, Ganad D. Neka, Aleisha M. G. Roberts, Yu Sun, Lili Benitez Angeles, Hannah I. Angulo Espinoza, Ellis A. Strutton, Esther R. Mbiwan, Jayeshbhai Chaudhari, Woojae Choi, Michelle Lifton, Pablo Penaloza-MacMaster, Dan H. Barouch

Background/Objectives: Classical major histocompatibility complex (MHC)-restricted T cells play essential roles in tuberculosis (TB) immunity. Characterizing the antigen targets, dominant epitopes, and MHC restriction of protective T-cell responses is important for understanding TB immunity and next-generation TB vaccine development. Methods: We recently used vaccine screening in mice to identify Rv1387 (PPE20), Rv0287 (EsxG), Rv1788 (PE18), and Rv1886c (Ag85B) as protective antigens, and in this paper, characterized the T-cell responses to these antigens in mice. Results: We first identified the full repertoire of CD4 and CD8 T-cell epitopes in C57BL/6 and BALB/c mice. We further defined the MHC class I and II restriction of immunodominant epitopes, enabling the development and validation of tetramers for probing cognate T-cell responses. Finally, we used these tetramers to contrast lung mucosal T-cell phenotypes in the setting of Bacillus Calmette–Guérin (BCG) and mRNA vaccination. Conclusions: These results define the T-cell epitopes and MHC restriction of next-generation TB vaccine antigens and contribute reagents for studying TB T-cell immunity.